The impact of switching to race-neutral reference equations on FEV1 percent predicted among people with cystic fibrosis,*

被引:1
|
作者
Rosenfeld, Margaret [1 ,2 ]
Cromwell, Elizabeth A. [3 ]
Schechter, Michael S. [4 ]
Ren, Clement [5 ]
Flume, Patrick A. [6 ]
Szczesniak, Rhonda D. [7 ]
Morgan, Wayne J. [8 ]
Jain, Raksha [9 ]
机构
[1] Univ Washington, Dept Pediat, Seattle, WA USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Cyst Fibrosis Fdn, Patient Registry Res, Bethesda, MD 20814 USA
[4] Viriginia Commonwealth Univ, Div Pulm & Sleep Med, Childrens Hosp Richmond, Richmond, VA USA
[5] Childrens Hosp Philadelphia, Div Pulm & Sleep Med, Philadelphia, PA USA
[6] Med Univ South Carolina, Div Pulm Crit Care Allergy & Sleep Med, Charleston, SC USA
[7] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA
[8] Univ Arizona, Pediat Pulm & Sleep Med, Tucson, AZ USA
[9] Univ Texas Southwestern, Internal Med, Dallas, TX USA
关键词
Cystic fibrosis; Respiratory function tests; Forced expiratory volume; LUNG-FUNCTION; FIBROSIS;
D O I
10.1016/j.jcf.2024.03.013
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: The American Thoracic Society recommended switching to race-neutral spirometry reference equations, as race is a social construct and to avoid normalizing disparities in lung function due to structural racism. Understanding the impact of the race-neutral equations on percent predicted forced expiratory volume in one second (ppFEV1) in people with cystic fibrosis (PwCF) will help prepare patients and providers to interpret pulmonary function test results. Objective(s): To quantify the impact of switching from Global Lung Initiative (GLI) 2012 race-specific to GLI 2022 Global race-neutral reference equations on the distribution of ppFEV1 among PwCF of different races. Methods: Cross-sectional analysis of FEV1 among PwCF ages >= 6 years in the 2021 U.S. Cystic Fibrosis Foundation Patient Registry. We describe the absolute difference in ppFEV1 between the two reference equations by reported race and the effect of age and height on this difference. Results: With the switch to GLI Global, ppFEV1 will increase for White (median increase 4.7, (IQR: 3.1; 6.4)) and Asian (2.6 (IQR: 1.6; 3.7)) individuals and decrease for Black individuals (-7.7, (IQR: -10.9; -5.2)). Other race categories will see minimal changes in median ppFEV1. Individuals with higher baseline ppFEV1 and younger age will see a greater change in ppFEV1 (i.e., a greater improvement among White and Asian individuals and a greater decline among Black individuals). Conclusions: Switching from GLI 2012 race-specific reference equations to GLI 2022 Global race-neutral equations will result in larger reductions in ppFEV1 among Black individuals with CF than increases among White and Asian people with CF.
引用
收藏
页码:443 / 449
页数:7
相关论文
共 36 条
  • [1] CORRELATION OF SWEAT CHLORIDE AND PERCENT PREDICTED FEV1 IN CYSTIC FIBROSIS PATIENTS TREATED WITH IVACAFTOR
    Fidler, M.
    Beusmans, J.
    Panorchan, P.
    Van Goor, F.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 270 - 270
  • [2] Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor
    Fidler, Meredith C.
    Beusmans, Jack
    Panorchan, Paul
    Van Goor, Fredrick
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (01) : 41 - 44
  • [3] Comparison of FEV1 reference equations for evaluating a cystic fibrosis therapeutic intervention
    Konstan, Michael W.
    Wagener, Jeffrey S.
    VanDevanter, Donald R.
    Pasta, David J.
    Millar, Stefanie J.
    Morgan, Wayne J.
    PEDIATRIC PULMONOLOGY, 2017, 52 (08) : 1013 - 1019
  • [4] THE GLI SPIROMETRY REFERENCE EQUATIONS INFLUENCE THE APPARENT RATE OF DECLINE IN FEV1 AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS
    Davies, G.
    Aurora, P.
    McDonald, A.
    Prasad, A.
    Bilton, D.
    Stocks, J.
    Stanojevic, S.
    THORAX, 2014, 69 : A37 - A37
  • [5] Is an FEV1 of 80% predicted a normal spirometry in cystic fibrosis children and adults?
    Konig, Peter
    Ner, Zarah
    Acton, James D.
    Ge, Bin
    Hewett, John
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (08): : 2397 - 2403
  • [6] Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis
    Boelle, Pierre-Yves
    Viviani, Laura
    Busson, Pierre-Francois
    Olesen, Hanne V.
    Ravilly, Sophie
    Stern, Martin
    Assael, Baroukh M.
    Barreto, Celeste
    Drevinek, Pavel
    Thomas, Muriel
    Krivec, Uros
    Mei-Zahav, Meir
    Vibert, Jean-Francois
    Clement, Annick
    Mehta, Anil
    Corvol, Harriet
    ORPHANET JOURNAL OF RARE DISEASES, 2012, 7
  • [7] REFERENCE PERCENTILES FOR FEV1 AND BMI IN EUROPEAN CHILDREN AND ADULTS WITH CYSTIC FIBROSIS
    Corvol, H.
    Boelle, P.
    Viviani, L.
    Busson, P.
    Olesen, H., V
    Ravilly, S.
    Stern, M.
    Assael, B. M.
    Barreto, C.
    Drevinek, P.
    Thomas, M.
    Krivec, U.
    Mei-Zahav, M.
    Vibert, J.
    Clement, A.
    Mehta, A.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 359 - 359
  • [8] Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis
    Pierre-Yves Boëlle
    Laura Viviani
    Pierre-Francois Busson
    Hanne V Olesen
    Sophie Ravilly
    Martin Stern
    Baroukh M Assael
    Celeste Barreto
    Pavel Drevinek
    Muriel Thomas
    Uros Krivec
    Meir Mei-Zahav
    Jean-François Vibert
    Annick Clement
    Anil Mehta
    Harriet Corvol
    Orphanet Journal of Rare Diseases, 7
  • [9] A Large Single Center's Clinical Experience with Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis and a Baseline FEV1 of Less Than 40 Percent Predicted
    Kapolka, R.
    Hunt, W. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [10] Comparison of Percent-predicted and Z-score Thresholds for Severity of Airflow Obstruction Using Race-specific Versus Race-neutral Reference Equations
    Brems, J. H.
    Balasubramanian, A.
    Putcha, N.
    Fawzy, A.
    Hansel, N. N.
    Wise, R. A.
    Mccormack, M. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209